Article Text

PDF

Effect of an α2 agonist (mivazerol) on limiting myocardial ischaemia in stable angina

Abstract

A specific α2 agonist, mivazerol, known to be effective in reducing myocardial ischaemia when given intravenously immediately before an exercise tolerance test, produced a significant increase in exercise duration and time to the onset of angina when given orally over a two week period to 25 patients with stable angina. A non-significant trend to reduction in electrocardiographic signs of ischaemia was also noted. The clinical relevance of this improvement now needs to be tested in larger numbers.

  • α2 agonist
  • sympathetic activity
  • myocardial ischaemia
  • stable angina
  • exercise tolerance test
View Full Text

Statistics from Altmetric.com

Footnotes

  • Professor de Bono died since this article was submitted for publication.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.